Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Bloodstream Infection
100%
Infection
42%
Enterococcus faecium
39%
Vancomycin
36%
Ciprofloxacin
31%
Carbapenem
31%
Escherichia coli
25%
Levofloxacin
23%
Malignant Neoplasm
23%
Diseases
23%
Stenotrophomonas maltophilia
22%
Clinical Feature
22%
Acute Pyelonephritis
21%
Penicillinase
21%
Case-Control Study
19%
Piperacillin Plus Tazobactam
19%
Vancomycin-Resistant Enterococcus
18%
Hematologic Malignancy
18%
Methicillin-Resistant Staphylococcus Aureus
18%
Cohort Study
16%
Infectious Agent
16%
Extended Spectrum Beta Lactamase
16%
Cotrimoxazole
16%
Tigecycline
14%
Rifampicin
14%
Galactomannan
14%
Teicoplanin
14%
Middle East Respiratory Syndrome
14%
Posaconazole
14%
Antimicrobial Therapy
14%
Staphylococcus aureus
14%
Enterobacteriales
14%
Urinary Tract Infection
14%
Quinolone Derivative
13%
Recurrent Disease
12%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
12%
Antibiotics
9%
Acinetobacter
9%
Systemic Mycosis
9%
Invasive Aspergillosis
8%
Hospital Infection
7%
Lung Tuberculosis
7%
Pharmacokinetic
7%
Colistimethate
7%
Adverse Outcome
7%
Bacterial Peritonitis
7%
Parvimonas micra
7%
Tablet
7%
Rifabutin
7%
Coronavirinae
7%
Medicine and Dentistry
Bloodstream Infection
62%
Middle East Respiratory Syndrome
38%
Infection
33%
Odds Ratio
23%
Cohort Analysis
22%
Kidney Graft
22%
Penicillinase
21%
Catheter Infection
21%
COVID-19
21%
Extended Spectrum Beta Lactamase
18%
Clinical Feature
16%
Carbapenem
15%
Stenotrophomonas maltophilia
15%
Streptococcus pneumonia
15%
Pneumococcal Pneumonia
15%
Escherichia coli
14%
Galactomannan
14%
Staphylococcus aureus
14%
Fungal Infection
14%
Cytomegalovirus
14%
Liver Graft
14%
Enterobacteriales
14%
Middle East Respiratory Syndrome Coronavirus
14%
Surgical Infection
14%
Piperacillin/Tazobactam
14%
Antimicrobial Therapy
14%
Mycosis
14%
Urinary Tract Infection
14%
Multivariate Analysis
13%
Quinolone Derivative
12%
Tertiary Care
12%
Malignant Neoplasm
11%
Case-Control Study
11%
Hazard Ratio
11%
Hematologic Malignancy
11%
Cytomegalovirus Infection
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Levofloxacin
10%
Kidney Transplantation
10%
Retrospective Cohort Study
10%
Pathogen
9%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
9%
Blood Culture
9%
Ciprofloxacin
9%
Molecular Epidemiology
9%
Immunocompromised Patient
9%
Liver Transplantation
9%
Mortality Rate
9%
Wassermann Test
9%
Invasive Aspergillosis
8%
Immunology and Microbiology
Enterococcus faecium
39%
Prevalence
35%
Severe Acute Respiratory Syndrome Coronavirus 2
31%
Vancomycin-Resistant Enterococcus
31%
Staphylococcus aureus
29%
Escherichia coli
26%
Methicillin-Resistant Staphylococcus Aureus
26%
Infectious Agent
25%
Minimum Inhibitory Concentration
23%
Omicron Coronavirus Variant
21%
Methicillin Susceptible Staphylococcus Aureus
21%
Klebsiella pneumoniae
19%
COVID-19
18%
Stenotrophomonas maltophilia
18%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
18%
Microorganism
18%
Immunosuppressant
18%
Molecular Epidemiology
16%
Vancomycin Resistance
15%
Plasmid
15%
Breakthrough Infection
14%
Vancomycin Intermediate Staphylococcus Aureus
14%
Hematopoietic Stem Cell Transplantation
14%
Enterobacter Cloacae
14%
Infectious Disease
14%
Infection
14%
Mortality Rate
12%
C-Reactive Protein
12%
Electronic Medical Record
11%
Titer
10%
Adoptive Immunity
9%
Gene Mutation
9%
Multilocus Sequence Typing
8%
Antibiotic Sensitivity
8%
Immunogenicity
8%
Glycopeptide
7%
Enterobacter
7%
Broth Dilution
7%
Multiplex Polymerase Chain Reaction
7%
Serology
7%
Humoral Immunity
7%
Neisseria gonorrhoeae
7%
Body Fluid
7%
Bacterium Identification
7%
Plaque Reduction Neutralization Test
7%
Candida tropicalis
7%
Acute Phase Protein
7%
Amino Acid Substitution
7%
Inflammation Response
7%
Antimicrobial Resistance
7%